She has repeatedly emphasized that her decision was personal, pushing back against public scrutiny and reminding audiences that weight loss journeys are not anyone elses business

Helpful evidence may include: Medication records Prescription records and pharmacy printouts showing the specific GLP-1 drug, dosage, and dates of use Any compounded or telehealth-prescribed products, including labels, receipts, or online order confirmations Eye and hospital records Emergency department notes from the day you first reported vision changes Ophthalmology and neuro-ophthalmology records, including exam findings Imaging and diagnostic tests (OCT scans, visual field testing, MRI reports, etc.) Timeline documentation A clear chronology showing when you started the medication, when your symptoms began, and how they progressed Records of dose changes, interruptions, or switches between GLP-1 products Impact on your life Employer records showing time missed from work or job loss Statements from family or friends documenting how vision loss has changed your daily activities Evidence of assistive devices, home modifications, or support services you now need Our firm works closely with medical experts to connect the medical facts to the legal claims in a way that meets the standards of federal courts and any applicable MDL orders

A similar study noted that ipamorelin administration in female rats resulted in increased bone mineral content, which is suggestive of stronger, denser bones [5]
Semaglutide is the dynamic fixing in Ozempic, Wegovy, and Rybelsus
For more on this, read Fibermaxxing for Weight Loss
Consult a healthcare professional before starting any new prescription protocol